Author | Leah Lawrence


Subcutaneous Rituximab Maintained Efficacy, Was Safe in DLBCL, FL

October 09, 2019

Switching from intravenous to subcutaneous administration of rituximab for non-Hodgkin diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) resulted in similar efficacy with no new safety issues.

Optimal Treatment for Early-Stage Follicular Lymphoma Still Not Established

October 09, 2019

The international retrospective study included 365 patients with newly diagnosed early-stage follicular lymphoma rigorously staged with PET-CT and bone marrow biopsy.

Social Media Recruiting for Trials Falls Short

October 08, 2019

A survey of physicians found recruiting for trials through social media can be useful, but not for cancer therapeutic trials.

Potency of CAR T-Cell Therapy for Myeloma May Vary by Disease Stage

October 07, 2019

CAR T cells are a more effective therapy if manufactured for patients with multiple myeloma prior to the onset of relapsed or refractory disease.